A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.
Shepp DH, Ramirez-Ronda C, Dall L, Pollard RB, Murphy RL, Kessler H, Sherer R, Mertz G, Perez G, Gocke DJ, Greenberg SB, Petersen E, Frank I, Moore MD, McKinnis R, Rooney JF.
Shepp DH, et al. Among authors: mckinnis r.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):283-8. doi: 10.1097/00042560-199708010-00006.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997.
PMID: 9292587
Clinical Trial.